You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult lymphocyte predominant Hodgkin lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quality of Life in Adult and Pediatric Nodular

Recruiting
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    • Aurora, Colorado
    • +1 more
    Oct 27, 2023

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Completed
    Has Results
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +5 more
    • gemcitabine hydrochloride
    • bendamustine hydrochloride
    • Atlanta, Georgia
    • +1 more
    Oct 21, 2021

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Active, not recruiting
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +16 more
    • 6,8-bis(benzylthio)octanoic acid
    • bendamustine hydrochloride
    • Winston-Salem, North Carolina
    • +1 more
    Apr 8, 2022

    Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

    Not yet recruiting
    • Nodular Lymphocyte Predominant Hodgkin Lymphoma
    • +2 more
    • Biopsy
    • +9 more
    • (no location specified)
    Jun 1, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
    • (no location specified)
    Feb 14, 2023

    Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Trial in Cologne (Ibrutinib)

    Completed
    • Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Apr 6, 2021

    Lymphoma Trial in Giessen (drug, other, procedure)

    Active, not recruiting
    • Lymphoma
    • Giessen, Germany
      Universitaetsklinikum Giessen-Marburg
    May 10, 2021

    Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

    Withdrawn
    • Leukemia
    • Stem Cell Transplantation
    • Munich, Bavaria, Germany
      3. Medizinische Klinik, Klinikum rechts der Isar der TU München
    Dec 5, 2022

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

    Not yet recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Beijing, China
    • +3 more
    Jul 20, 2023

    Hodgkin Lymphoma Trial in Latakia (First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3

    Recruiting
    • Hodgkin Lymphoma
    • First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3 and third analysis: Lymphocyte/Monocyte ratio > or = 2.9
    • First analysis: Lymphocyte count < 1500 cells per microlitre, second analysis: IPS > or = 3 and third analysis: Lymphocyte/Monocyte ratio < 2.9
    • Latakia, Syrian Arab Republic
      Tishreen University
    Feb 14, 2022

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

    Not yet recruiting
    • COVID-19
    • +2 more
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Oct 27, 2022

      Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

      Not yet recruiting
      • Mature B-Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 6, 2022

      Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

      Unknown status
      • Adult Lymphocyte Depletion Hodgkin Lymphoma
      • +6 more
      • brentuximab vedotin
      • +11 more
      • Stanford, California
      • +6 more
      Feb 14, 2020

      Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

      Recruiting
      • Advanced or Metastatic Solid Tumors
      • Non-Hodgkin Lymphoma
      • San Antonio, Texas
        NEXT Oncology
      Jan 6, 2023

      Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

      Active, not recruiting
      • Refractory Non Hodgkin Lymphoma
      • Relapsed Non Hodgkin Lymphoma
      • rituximab
      • +7 more
      • Sacramento, California
        University of California Davis
      Nov 28, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

      Recruiting
      • NHL
      • NHL, Relapsed, Adult
      • Birmingham, Alabama
      • +4 more
      May 31, 2023

      Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin's, Adult
      • (no location specified)
      Aug 4, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022